True or False: Patients with end stage liver disease are generally managed with hemodialysis.

Patients with end-stage liver disease are typically not managed with hemodialysis as a routine treatment. Instead, the primary focus is on addressing liver function and related complications. Hemodialysis is primarily used for individuals with end-stage renal disease, where kidney function is severely compromised.

In cases of end-stage liver disease, interventions often focus on liver transplantation or managing complications such as hepatic encephalopathy, variceal bleeding, and ascites through other medical and surgical therapies. While some patients may experience kidney dysfunction secondary to liver disease, known as hepatorenal syndrome, that does not imply that systemic hemodialysis becomes the mainstay treatment for these patients. Instead, treatment approach may include supportive care, renal replacement therapy, or ultimately a transplant strategy depending on the overall condition of the patient and the severity of both liver disease and renal function.

Therefore, stating that patients with end-stage liver disease are generally managed with hemodialysis is inaccurate, making the answer false.